Stox Media

Stox Media

Benzinga Contributor

Silo Pharma Enters into Sponsored Research Agreement with the University of Maryland, Baltimore
Company Analyzing Efficacy of Novel Joint Homing Peptide ART-1 for Rheumatoid Arthritis Next steps include targeted approach to delivering Psychedelics including Psilocybin and Ketamine
Sponsored
Silo Pharma Announces Collaboration with University California San Francisco to study Psilocybin as an Anti-Inflammatory agent in Parkinson's and Bipolar Patients
Englewood Cliffs, NJ, June 8, 2021 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB: SILO) a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, is pleased to announce that it has entered into a Scientific Research Agreement (SRA) with the Univer
Sponsored
Minerco (MINE) Developer of SHRUCOIN a Cryptocurrency That Can Be Purchased Online With VISA & MasterCard, Launches Shrucoin Pay Platform For Online Payments That Allows Merchants to Accept Bitcoin, Ethereum, Bitcoin Cash, Litecoin, DASH and EOS for Cannabis & Psychedelics Sales
Company Also In Talks To Acquire Cannabis Mobile Delivery Services To Utilize Shrucoin Pay As Method Of Payment: Will Allow Company To Enter Into The Rapidly Growing Global Cannabis Dispensary Delivery Services Market Which Is Expected To Reach $30 Billion By 2024  
Rap Artist Bobby Shmurda To Use Minerco's Blockchain Press Release
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.